Institutional Ownership Allogene Therapeutics, Inc. (ALLO)
This table provides information about the institutional ownership of Allogene Therapeutics, Inc. (ALLO). We have compiled data on the 176 institutions that hold shares in the stock, with a total of 165 Million shares, which have been reported (via 13F filing form) to have a value of $174 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tpg Gp A, LLC
Fort Worth, TX |
May 15, 2025 Q1 2025 |
18,716,306
shares
|
$19.8 Million
0.84% of portfolio
|
Q4 2021
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
16,445,682
shares
|
$17.4 Million
0.0% of portfolio
|
Q2 2024
Added 70.37%
|
|
|
Capital World Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
12,265,330
shares
|
$13 Million
0.0% of portfolio
|
Q1 2025
Added 77.85%
|
|
|
Lynx1 Capital Management LP
San Juan, PR |
May 15, 2025 Q1 2025 |
11,057,009
shares
|
$11.7 Million
5.97% of portfolio
|
Q1 2025
Added 1.68%
|
|
|
Darwin Global Management, Ltd.
St. Helier, Y9 |
May 15, 2025 Q1 2025 |
10,449,791
shares
|
$11.1 Million
1.06% of portfolio
|
Q1 2025
New holding
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
10,203,329
shares
|
$10.8 Million
0.0% of portfolio
|
Q1 2025
Added 90.75%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
8,067,553
shares
|
$8.55 Million
0.0% of portfolio
|
Q1 2025
Added 0.84%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
5,853,974
shares
|
$6.21 Million
0.0% of portfolio
|
Q1 2025
Added 177.89%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
5,136,797
shares
|
$5.45 Million
0.0% of portfolio
|
Q1 2025
Added 37.49%
|
|
|
Primecap Management CO
Pasadena, CA |
May 09, 2025 Q1 2025 |
4,931,840
shares
|
$5.23 Million
0.01% of portfolio
|
Q1 2025
Added 0.09%
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
4,360,608
shares
|
$4.62 Million
0.04% of portfolio
|
Q1 2025
Added 0.01%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
4,206,004
shares
|
$4.46 Million
0.0% of portfolio
|
Q1 2025
Reduced 6.23%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
3,868,750
shares
|
$4.1 Million
0.36% of portfolio
|
Q1 2025
Added 34.91%
|
|
|
Foresite Capital Management Vi LLC
Larkspur, CA |
May 15, 2025 Q1 2025 |
3,448,275
shares
|
$3.66 Million
2.76% of portfolio
|
Q4 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
3,359,438
shares
|
$3.56 Million
0.0% of portfolio
|
Q1 2025
Added 3.92%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
3,179,853
shares
|
$3.37 Million
0.0% of portfolio
|
Q1 2025
Reduced 10.72%
|
|
|
Wildcat Capital Management, LLC
|
May 02, 2025 Q1 2025 |
2,920,787
shares
|
$3.1 Million
2.5% of portfolio
|
Q2 2024
Added 52.06%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
2,789,777
shares
|
$2.96 Million
0.0% of portfolio
|
Q1 2025
Reduced 61.52%
|
|
|
Patient Square Capital LP
Menlo Park, CA |
May 14, 2025 Q1 2025 |
2,368,186
shares
|
$2.51 Million
1.43% of portfolio
|
Q1 2025
Added 58.95%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
2,353,101
shares
|
$2.49 Million
0.0% of portfolio
|
Q1 2025
Added 135.64%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
2,200,800
shares
|
$2.33 Million
0.01% of portfolio
|
Q1 2025
Reduced 18.56%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
2,143,110
shares
|
$2.27 Million
0.0% of portfolio
|
Q1 2025
Added 169.07%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
2,075,099
shares
|
$2.2 Million
0.01% of portfolio
|
Q1 2025
Reduced 23.49%
|
|
|
Vida Ventures Advisors, LLC
|
Apr 03, 2025 Q1 2025 |
1,798,163
shares
|
$1.91 Million
55.14% of portfolio
|
Q3 2020
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
1,556,700
shares
|
$1.65 Million
0.0% of portfolio
|
Q1 2025
Added 180.72%
|